Our webinar series features joint presentations by researchers and patient partners highlighting individual research projects and other Can-SOLVE CKD activities. The webinars are interactive, starting with a short presentation that is followed by discussion and Q&A from network members.
Full recordings of completed webinars are available below and on our YouTube channel.
Impact of cell therapy to prevent the loss of kidney function
July 5, 2017
Presenter: Dr. Richard Gilbert
Diabetes is the most common cause of end-stage kidney failure in Canada. The main cause of reduced kidney function in diabetes is the slow loss of small blood vessels (capillaries) combined with scar tissue (fibrosis). Studies by Dr. Richard Gilbert and colleagues have shown that cells from the bone marrow can be used to restore blood vessels and prevent excessive scar tissue formation in the kidney.
In this webinar, Dr. Gilbert discusses a pilot test that will use bone marrow-derived cells to prevent the loss of kidney function.
The historical context for Indigenous health in Canada
June 29, 2017
Presenters: Dr. Malcolm King and Dr. Jon McGavock
On June 29, the Can-SOLVE CKD Network and Diabetes Action Canada co-hosted a discussion on the history of Indigenous health in Canada and what it can teach us about engaging Indigenous individuals and communities.
Strategies to enhance patient self-management of chronic kidney disease
June 7, 2017
Presenters: Dr. Brenda Hemmelgarn, Ms. Gwen Herrington, Mr. Dwight Sparkes
Patients with chronic kidney disease need to balance their complex medical condition with the demands of daily life while maintaining emotional well-being.
Dr. Brenda Hemmelgarn and colleagues are working to understand how we can empower patients to self-manage their chronic kidney disease to improve disease progression and overall patient experience and well-being.
The perspectives of patients and caregivers will direct the development of a range of self-management support strategies that can be individualized to patients’ unique situations, needs, priorities and preferences.
Targeted deprescribing in patients on hemodialysis to reduce polypharmacy
May 10, 2017
Presenters: Dr. Marisa Battistella
Patients on hemodialysis take an average of 12 medications per day. Many of these medications lack high-quality evidence to show their effectiveness and safety in people with chronic kidney disease.
A team led by Dr. Marisa Battistella is working to develop and validate “deprescribing” tools that will reduce the use of unnecessary medications in hemodialysis units across Canada.
Increasing the number of living donor kidney transplants
May 4, 2017
Presenters: Dr. Amit Garg, Mr. Ken Litchfield, Ms. Leah Getchell, Ms. Susan McKenzie
Transplantation offers kidney patients longer life and renewed quality of life, all at a fraction of the cost of dialysis. Unfortunately, there are too few deceased donors to meet the demand for transplantable kidneys.
This project will develop solutions to help overcome barriers to living kidney donor transplantation. It will also evaluate the impact of these solutions on patient experiences, outcomes and health care system costs.
Risk prediction to support shared decision-making for managing heart disease
April 19, 2017
Presenters: Ms. Winnie Pearson, Dr. Juli Finlay, Ms. Pantea Javaheri, Dr. Matthew James
Heart disease is very common in people with chronic kidney disease (CKD) and is a major cause of hospitalization, reduced quality of life, and shortened survival. When people with CKD develop heart problems they are much less likely to receive tests and procedures for their heart than people without CKD.
A team led by Dr. Matthew James is developing tools that can help doctors share personalized information on the benefits and risks of having a heart procedure to help patients better communicate their own values and preferences to their doctor. This “shared decision-making” approach, developed with patients and health care providers, aims to improve the experience and quality of care for CKD patients managing heart disease.
Integrating risk-based care for patients with CKD in the community
April 5, 2017
Presenters: Dr. Navdeep Tangri, Cathy Woods
A small but important minority of patients require timely specialist referral in order to delay the progression of kidney disease and make appropriate treatment decisions.
Dr. Navdeep Tangri and colleagues have developed a mathematical equation that can predict the risk of kidney failure requiring dialysis over a two- or five-year period in patients with chronic kidney disease.
In this webinar, Dr. Tangri highlights how the team is working to convert this equation into a useful, interactive clinical decision tool that can actually guide doctors and patients to appropriate and timely referrals.
Improving Indigenous patient knowledge about treatment options for failing kidneys
March 22, 2017
Presenters: Dr. Joanne Kappel, Dr. Jack Hicks
Chronic kidney disease patients and their families face many complex decisions, including which dialysis treatment to choose, whether to pursue a transplant, or whether to have non-dialysis supportive care.
Studies show that there are different ways to support patients in getting the information they need to help them make hard decisions. These have not been formally evaluated in those with CKD.
This webinar discusses how we can better understand the barriers faced by patients with kidney disease and create an educational program that adjusts to the needs of individual patients.
Defining CKD risk in youth with diabetes
February 8, 2017
Presenters: Dr. James Scholey, Dr. Farid Mahmud, Dr. Allison Dart, Jackie McKee
Diabetes is the most common cause of both chronic kidney disease and kidney failure in North America. Rates of both Type 1 and Type 2 diabetes are increasing in children, with important impacts on health in early adulthood; however, we are not yet able to predict who is at risk for CKD or for progression to kidney failure.
This webinar highlights two Can-SOLVE CKD projects, the AdDIT and iCARE studies, that are working to discover and confirm which youth with diabetes are at risk for CKD.
State of the Network
January 25, 2017
Presenters: Dr. Adeera Levin, Dr. Braden Manns, Kate Chong, Mary Beaucage
Dr. Adeera Levin, Dr. Braden Manns, and members of our Patient Council and the Indigenous Peoples’ Engagement & Research Council provide an overview of the what the network has accomplished, what is currently underway, and what have we planned for 2017.